Linaliglip M 2.5/500mg Tablet 15s

Linaliglip M 2 5 500mg Tablet 15s (Linagliptin + Metformin) is a fixed-dose combination oral antidiabetic medicine used to improve blood sugar control in adults with type 2 diabetes mellitus. It combines two complementary mechanisms to help regulate glucose levels more effectively when diet, exercise, or a single medication is not sufficient. This combination supports better glycemic control while reducing the need for multiple tablets in daily therapy.

Linaliglip M 2 5 500mg Tablet 15s is a fixed-dose oral antidiabetic medicine that combines Linagliptin, a DPP-4 inhibitor, and Metformin hydrochloride, a biguanide. It is used in adults with type 2 diabetes mellitus when blood sugar is not adequately controlled with lifestyle measures or a single medicine.

This combination works through complementary mechanisms to improve glycemic control. Linagliptin enhances incretin activity, which increases insulin release in response to meals and reduces excessive glucagon secretion from the liver. Metformin reduces hepatic glucose production and improves the body’s sensitivity to insulin in peripheral tissues. Together, these actions help regulate both fasting and post-meal blood glucose levels, leading to improved long-term control as reflected in HbA1c reduction.

The medicine is widely used as part of long-term diabetes management to support stable blood sugar control and reduce the risk of diabetes-related complications, including cardiovascular, renal, and neurological conditions. It is generally associated with a low risk of hypoglycemia when used alone and is considered weight-neutral in most patients.

Because Metformin is primarily eliminated through the kidneys, renal function should be monitored regularly during treatment. Gastrointestinal side effects may occur, especially at the start of therapy or during dose adjustments. Rarely, a serious condition called lactic acidosis may occur, particularly in patients with significant kidney impairment. This medicine should be used under medical supervision, along with an appropriate diet and exercise, to ensure safe and effective long-term diabetes management.

Linaliglip M 2 5 500mg Tablet 15s may be indicated by your doctor for:

Type 2 Diabetes Mellitus

For the treatment of adults with type 2 diabetes mellitus to improve glycemic control when lifestyle measures or single‑drug therapy are insufficient.

Combination Therapy

For patients who require a dual oral antidiabetic regimen to achieve better blood sugar control and long‑term management of the condition.

Linaliglip M 2 5 500mg Tablet 15s may provide benefits such as:

• Lowers both fasting and post-meal blood glucose levels through a dual-action approach.

• Helps achieve and maintain target HbA1c levels, reducing the long-term risk of diabetic complications.

• Offers a simplified treatment routine by combining two medicines into a single tablet.

• Features a weight-neutral profile, which is beneficial for patients managing their weight.

• Carries a low risk of causing hypoglycemia when used as a primary therapy.

• Promotes better metabolic health by addressing insulin resistance and secretion simultaneously.

• Provides a predictable response that works in harmony with the body's natural response to food.

Linaliglip M 2 5 500mg Tablet 15s may cause side effects in some individuals. Many people find that digestive symptoms improve as the body adjusts to the medication.

Common side effects of Linaliglip M 2 5 500mg Tablet 15s may include

• Diarrhoea or loose stools

• Nausea or vomiting

• Stomach upset or abdominal pain

• Headache

• Sore throat or stuffy nose

Uncommon side effects of Linaliglip M 2 5 500mg Tablet 15s may include

• Loss of appetite

• Metallic taste in the mouth

• Excessive gas or bloating

Serious side effects that may require immediate medical attention include

• Lactic Acidosis: A rare but serious buildup of acid in the blood, causing muscle pain, weakness, or trouble breathing.

• Pancreatitis: Severe and persistent stomach pain that may radiate to the back.

• Severe Joint Pain: Intense or persistent pain in the joints.

• Bullous Pemphigoid: Blistering or breakdown of the skin surface.

• Severe Allergic Reaction: Swelling of the face, lips, or throat, or difficulty breathing.

• Always consult your doctor if you notice any unusual symptoms while taking Linaliglip M 2 5 500mg Tablet 15s.

Use Linaliglip M 2 5 500mg Tablet 15s exactly as directed by your doctor based on your condition.

• Take the tablet as directed, usually twice daily with meals.

• Taking the medicine with food is highly recommended to reduce stomach upset and diarrhoea.

• Swallow the tablet whole with water; do not crush, chew, or break the tablet.

• Try to take your doses at the same time every day to maintain steady medicine levels.

• If you are taking an extended-release form, do not split the tablet as it may interfere with how the medicine is released.

• Follow the diet and exercise plan provided by your healthcare team for the best results.

Linaliglip M 2 5 500mg Tablet 15s works through two pathways to regulate blood sugar levels. Linagliptin blocks the enzyme DPP-4, which is responsible for breaking down incretin hormones. By keeping these hormone levels higher, it triggers the pancreas to release more insulin when blood sugar is high and tells the liver to stop making excess sugar.

Metformin works mainly in the liver to decrease the production of glucose. It also increases the sensitivity of muscle cells to insulin, allowing the body to remove sugar from the blood more efficiently. Together, these actions lower the amount of sugar the liver makes, reduce the amount of sugar the intestines absorb, and help the body use its own insulin better.

• Always take this medication with your morning and evening meals to minimise stomach upset.

• Digestive side effects like diarrhoea usually get better after a few weeks as your body gets used to the metformin.

• If you are scheduled for an X-ray or CT scan involving contrast dye, inform your doctor, as you may need to stop the medicine temporarily.

• Carry a source of sugar, like sugar candy, in case you experience low blood sugar while on combination therapy.

• Do not skip meals while taking this medication to help keep your blood sugar stable throughout the day.

• Regular exercise and a healthy diet are essential to help manage your condition effectively.

• Store at room temperature in a dry place away from heat and direct sunlight.

• Keep the tablets in their original packaging to protect them from moisture.

• Keep out of the reach of children and pets.

• Do not use the medicine after the expiry date printed on the packaging.

• General Diet (No Interaction): Can be taken with meals to improve gastrointestinal tolerance and reduce stomach upset.

• Alcohol (Severe): Alcohol use significantly increases the risk of lactic acidosis, a rare but serious complication of Metformin. It may also worsen blood sugar control. Patients should avoid alcohol during treatment.

• Insulin or Sulfonylureas (Moderate): Concomitant use may increase the risk of hypoglycemia; dose adjustment may be required.

• Rifampin (Moderate): May lower plasma concentrations of Linagliptin, reducing its effectiveness.

• Diuretics (Mild): Certain diuretics can impair glycemic control; blood sugar should be monitored more closely.

• Corticosteroids (Mild): Systemic corticosteroids may raise blood glucose levels, requiring adjustment of antidiabetic therapy.

• Severe Kidney Disease (Severe): Contraindicated in patients with advanced renal impairment (eGFR < 30 mL/min) due to increased risk of lactic acidosis.

• Metabolic Acidosis (Severe): Contraindicated in patients with acute or chronic metabolic acidosis, including diabetic ketoacidosis.

• Pancreatitis (Caution): Use with caution in patients with a history of pancreatitis, as DPP‑4 inhibitors have been associated with rare cases.

• Heart Failure (Caution): Requires close monitoring in patients with heart failure, especially at initiation, since fluid balance and metabolic stress may complicate therapy.

Taking an excessive amount of Linaliglip M 2 5 500mg Tablet 15s may lead to severe hypoglycemia or a condition called lactic acidosis. Symptoms may include feeling very weak, cold, dizzy, or having a slow heart rate. If an overdose is suspected, seek emergency medical assistance immediately.

If you miss a dose, take it with food as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and return to your regular schedule. Do not take two doses at once to make up for a missed application.